A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
Clinical trial NCT06907875 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06907875
- Sponsor
- Epicrispr Biotechnologies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2027-07-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.